# Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

> **NCT02805504** · PHASE4 · COMPLETED · sponsor: **Loma Linda University** · enrollment: 136 (actual)

## Conditions studied

- Urinary Tract Diseases

## Interventions

- **DRUG:** Exparel
- **DRUG:** Marcaine

## Key facts

- **NCT ID:** NCT02805504
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-11
- **Primary completion:** 2022-05-09
- **Final completion:** 2022-05-09
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805504, "Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02805504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*